Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
15.26B | 14.66B | 15.67B | 13.68B | 12.25B | Gross Profit |
12.52B | 7.41B | 7.68B | 7.67B | 7.15B | EBIT |
2.67B | 3.20B | 2.62B | 2.83B | 2.65B | EBITDA |
5.48B | 6.06B | 5.03B | 4.72B | 4.37B | Net Income Common Stockholders |
1.82B | 2.52B | 1.66B | 1.35B | 1.10B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.00M | 1.19B | 1.28B | 992.00M | 1.27B | Total Assets |
23.00B | 66.33B | 69.06B | 63.12B | 62.90B | Total Debt |
348.00M | 25.01B | 24.41B | 25.36B | 25.08B | Net Debt |
347.00M | 23.82B | 23.13B | 24.37B | 23.81B | Total Liabilities |
1.04B | 45.17B | 48.18B | 42.78B | 43.83B | Stockholders Equity |
21.96B | 21.16B | 20.69B | 20.04B | 18.85B |
Cash Flow | Free Cash Flow | |||
3.36B | -2.34B | -233.00M | -1.22B | -1.71B | Operating Cash Flow |
3.36B | 2.16B | 3.94B | 2.73B | 2.20B | Investing Cash Flow |
-4.92B | -1.00B | -4.57B | -3.48B | -4.22B | Financing Cash Flow |
1.80B | -1.49B | 1.01B | 461.00M | 2.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $34.22B | 32.31 | 7.04% | 2.95% | -2.20% | -55.73% | |
75 Outperform | $32.96B | 21.63 | 12.64% | 3.25% | -3.30% | 14.40% | |
74 Outperform | $39.38B | 20.86 | 8.44% | 3.06% | 4.23% | -27.02% | |
69 Neutral | $39.01B | 19.74 | 10.43% | 3.26% | -5.25% | 7.11% | |
67 Neutral | $38.75B | 21.93 | 11.22% | 3.13% | 6.13% | -31.01% | |
65 Neutral | $11.67B | 15.52 | 6.23% | 4.52% | 5.50% | -9.06% | |
64 Neutral | $36.06B | 14.26 | 9.10% | 0.43% | -0.04% | 6.80% |